Поисковый запрос: (<.>A=Estrov, Zeev$<.>) |
Общее количество найденных документов : 35
Показаны документы с 1 по 20
|
|
1.
| Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia // Blood, 1998. Vol. 92, N 9.-С.3090-3097
|
2.
| A Phase I study of recombinant interferon-'бета' in patients with advanced malignant disease // Clin. Cancer Res., 1999. Vol. 5, N 12.-С.3990-3998
|
3.
| A Phase I study of recombinant interferon-'бета' in patients with advanced malignant disease // Clin. Cancer Res., 1999. Vol. 5, N 12.-С.3990-3998
|
4.
| A Phase I study of recombinant interferon-'бета' in patients with advanced malignant disease // Clin. Cancer Res., 1999. Vol. 5, N 12.-С.3990-3998
|
5.
| BAX and PKC'альфа' modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia // Clin. Cancer Res., 2000. Vol. 6, N 4.-С.1401-1409
|
6.
| BAX and PKC'альфа' modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia // Clin. Cancer Res., 2000. Vol. 6, N 4.-С.1401-1409
|
7.
| Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia // Clin. Cancer Res., 1999. Vol. 5, N 12.-С.4041-4047
|
8.
| Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia // Clin. Cancer Res., 1999. Vol. 5, N 12.-С.4041-4047
|
9.
| Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia // Clin. Cancer Res., 1999. Vol. 5, N 12.-С.4041-4047
|
10.
| Caspase 2 and caspase 3 as predictors of complete remission and survival in adults with acute lymphoblastic leukemia // Clin. Cancer Res., 1999. Vol. 5, N 12.-С.4041-4047
|
11.
| E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway // Clin. Cancer Res., 2000. Vol. 6, N 1.-С.250-259
|
12.
| Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remission // Brit. J. Haematol., 2002. Vol. 117, N 4.-С.869-874
|
13.
| Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remission // Brit. J. Haematol., 2002. Vol. 117, N 4.-С.869-874
|
14.
| Complex biallelic IGH rearrangements in IgM-expressing Z-138 cell line: Involvement of downstream immunoglobulin class switch recombination // Genes, Chromosomes and Cancer, 2005. Vol. 42, N 2.-С.164-169
|
15.
| WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute meyloid leukemia (AML) // Anticancer Res., 2005. Vol. 25, N 3B.-С.1841-1850
|
16.
| WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute meyloid leukemia (AML) // Anticancer Res., 2005. Vol. 25, N 3B.-С.1841-1850
|
17.
| WP-1034, a novel JAK-STAT inhibitor, with proapoptotic and antileukemic activity in acute meyloid leukemia (AML) // Anticancer Res., 2005. Vol. 25, N 3B.-С.1841-1850
|
18.
| The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells // Invest. New Drugs, 2011. Vol. 29, N 6.-С.1206-1212
|
19.
| The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells // Invest. New Drugs, 2011. Vol. 29, N 6.-С.1206-1212
|
20.
| The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells // Invest. New Drugs, 2011. Vol. 29, N 6.-С.1206-1212
|
&uf('+1W2226#',v2226), ?>
|
|